<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28832801</article-id><article-id pub-id-type="pmc">5570395</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2016-0050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>MicroRNAs and Current Concepts on the Pathogenesis of Abdominal
Aortic Aneurysm</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Joviliano</surname><given-names>Edwaldo Edner</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Mauricio Serra</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tenorio</surname><given-names>Emanuel Junior Ramos</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Department of Surgery and Anatomy, Faculdade de Medicina de
Ribeir&#x000e3;o Preto, Universidade de S&#x000e3;o Paulo (FMRP-USP),
Ribeir&#x000e3;o Preto, SP, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Edwaldo Edner Joviliano, Faculdade de
Medicina de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo,
Departamento de Cirurgia e Anatomia, Av. Bandeirantes, 3900 - Ribeir&#x000e3;o
Preto, SP, Brazil - Zip code: 14048-900. E-mail:
<email>eejov@fmrp.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2017</year></pub-date><volume>32</volume><issue>3</issue><fpage>215</fpage><lpage>224</lpage><history><date date-type="received"><day>31</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>12</day><month>3</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Objective: Abdominal aortic aneurysm is an important cause of morbidity and
mortality in the elderly. Currently, the only way to prevent rupture and death
related to abdominal aortic aneurysms is through surgical intervention.
Endovascular treatment is associated with less morbidity than conventional
treatment. The formation of an aneurysm is a complex multifactorial process,
involving destructive remodeling of the connective tissue around the affected
segment of the aorta wall. MicroRNAs are small sequences of non-coding RNAs that
control diverse cellular functions by promoting degradation or inhibition of
translation of specific mRNAs. A profile aberrant expression of miRNAs has been
linked to human diseases, including cardiovascular dysfunction.</p></abstract><kwd-group><kwd>Aortic Aneurysm</kwd><kwd>Aortic Aneurysm, Abdominal</kwd><kwd>MicroRNAs</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AAA</td><td align="left" rowspan="1" colspan="1">= Abdominal aortic aneurysms</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="left" rowspan="1" colspan="1">= Chronic obstructive pulmonary disease</td></tr><tr><td align="left" rowspan="1" colspan="1">EVAR</td><td align="left" rowspan="1" colspan="1">= Endovascular aneurysm repair</td></tr><tr><td align="left" rowspan="1" colspan="1">JNK</td><td align="left" rowspan="1" colspan="1">= c-Jun N-terminal kinase</td></tr><tr><td align="left" rowspan="1" colspan="1">MMPs</td><td align="left" rowspan="1" colspan="1">= Matrix metalloproteinases</td></tr><tr><td align="left" rowspan="1" colspan="1">SMCs</td><td align="left" rowspan="1" colspan="1">= Smooth muscle cells</td></tr><tr><td align="left" rowspan="1" colspan="1">TAAs</td><td align="left" rowspan="1" colspan="1">= Thoracic aortic aneurysms</td></tr><tr><td align="left" rowspan="1" colspan="1">TIMPs</td><td align="left" rowspan="1" colspan="1">= Tissues by metalloproteinase inhibitors</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Abdominal aortic aneurysms (AAA) are more frequently found in clinical practice. An
AAA is a permanent dilation, located in the abdominal aorta (from the level of the
diaphragm and extending to its bifurcation to the right and left common iliac
arteries), that exceeds the normal diameter by 50% or is larger than 3 cm. Most
aneurysms are found in the infrarenal aorta, proximal to the aortic
bifurcation<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>The pathological processes involved in the formation of degenerative AAA include
upregulation of proteolytic pathways, apoptosis, oxidative stress, inflammation, and
loss of the arterial wall matrix<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Although AAA seems to be a focal lesion, ample evidence indicates
that the entire vascular system is abnormal in patients with AAA<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Molecular and biomechanical
changes found in remote AAA vasculature are similar to those present in the wall of
the aneurysm<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>The risk of AAA rupture increases as the diameter of the aorta increases. Mortality
after rupture is high; about 80% of those who arrive at the hospital and 50% of
those who undergo a ruptured AAA surgery will die. The basis for the management of
AAA disease is to diagnose it before the rupture and to offer elective surgical
correction at an opportune time<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>However, diagnosis is problematic since most aneurysms are asymptomatic until
rupture. The significantly reduced mortality after elective repair, compared to that
which occurs after rupture, has led to the development of screening programs with
ultrasound. Community-based screening services have been shown to reduce mortality
from AAA in men aged 65-79 years, but are not effective in women in whom the
prevalence of AAA is smaller<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><sec><title>Prevalence</title><p>Most of the early studies describing the occurrence of AAA were based on findings
in post-mortem examination or population-based series. Those studies estimated
the prevalence of AAA could be as high as 6% in selected populations<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Aneurysms are more prevalent
in white males and mortality increases with advancing age<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Subsequently, screening
programs in specific populations were used to describe the epidemiology of AAA.
They reported that the prevalence of AAA was between 4% and 8% in men aged 65-80
years<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Prevalence is approximately six times higher in men than in women<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. However, there is evidence
to indicate that AAA prevalence among women may be gradually increasing, with
women now representing one third of patients with rupture. The reason for this
trend is not fully understood. One explanation is that the increase reflects a
temporal change in the prevalence of smoking among women, which increased
between 1950 and 1970<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p></sec><sec><title>Incidence</title><p>The average annual incidence of new AAA diagnoses in Western populations is 0.4%
to 0.67%<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. That incidence
is ten times lower in Asian populations<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The incidence of AAA rupture is increasing. One
possible explanation for this is the decrease in mortality from cardiovascular
causes, thereby increasing longevity and providing insidious growth until AAA
rupture. The real magnitude of the mortality associated with the rupture of the
aorta is likely to be underestimated, particularly by reducing the number of
post-mortem examinations<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p></sec><sec><title>Risk Factors</title><sec><title>Gender</title><p>Men are at much greater risk of AAA than women. The reasons for this are
unclear, but it is likely to be a function of hormonal factors, genetic
susceptibility, and exposure to risk factors<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. When aneurysms are discovered unruptured
in women, there appears to be an association with family history<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. There is no evidence to
suggest that screening women for AAA is cost-effective<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.</p></sec><sec><title>Family History</title><p>Family history is a risk factor independent of the development of
atherosclerosis and AAA<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Several studies have reported a high prevalence of
AAA among siblings of patients with AAA<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. A positive family history of AAA is associated
with twice the risk of those with no family history<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p><p>The development of AAA is genetically complex. A number of familial cases and
twin studies have provided strong evidence that heredity contributes to the
formation of AAA<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. The
probability that the monozygotic twin of a person with AAA will develop an
aneurysm is 24%<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>The development of AAA is unlikely to be related to a mutation of a single
gene and various genetic factors are implicated. Susceptibility genes rather
than occasional genetic mutations are likely to be important, particularly
those that regulate the inflammatory mediators, tissue proteases and
cellular biology of smooth muscle cells (SMCs) <sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p></sec><sec><title>Heritable connective tissue disorders</title><p>Acquired connective tissue diseases are a typical reason for aortic aneurysms
in more youthful patients. Roughly 20% of thoracic aortic aneurysms (TAAs)
derive from disorders related with single gene mutations. In Marfan
disorder, collagen cross-linking is hindered by alterations in the
fibrillin-1 gene, predisposing patients to premature, severe cystic medial
degeneration. More than 600 distinct mutations in the fibrillin-1 gene on
chromosome 15 have been identified in patients with Marfan disorder.
Fibrillin deficiency prompts dysregulation of TGF-&#x003b2; signaling,
bringing about abnormal activation of vascular SMCs, overabundant deposits
of extracellular matrix components, abundant metalloproteinase discharge,
and invasion of macrophages. Marfan syndrome patients may develop thoracic
aortic aneurysms, dissection, aortic valvular ineptitude, and mitral valve
prolapse. Dilatation of the aortic root, which might be followed by
dissection and rupture, is seen in roughly 75% of such patients.
Musculoskeletal, visual, central nervous system, and pulmonary abnormalities
are nonvascular sequelae of Marfan disorder<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Patients with type IV Ehlers-Danlos
disorder have a defect in type III collagen production (COL3A1) that prompts
hindered arterial elasticity, dissections, aneurysm formation, and arterial
rupture most commonly including medium-sized arteries. Life expectancy of
patients with type IV Ehlers-Danlos disorder is drastically abbreviated,
with a median life expectancy of 48 years, attributable to a great extent to
arterial rupture<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.</p><p>When patients with generalized matrix deficiency diseases such as Marfan
disorder and Ehlers-Danlos disorder are excluded, important family histories
of AAA disease might be taken from 15% to 20% of patients with AAAs. The
risk of AAAs in males with a first-degree relative affected by the illness
is about fourfold higher than the risk in the general population, and
twin-based studies estimate a heritability of roughly 60%<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Loeys-Dietz disorder is an autosomal dominant disorder marked by mutations of
TGF-&#x003b2; receptor 1 or 2 (TGFBR1 or TGFBR2), prompting dysregulation of
TGF-&#x003b2; signaling. Widespread vascular dilatation and tortuosity,
musculoskeletal pathology, facial dysmorphology, and skin abnormalities are
characteristics of this disorder. Almost all patients present dilatation of
the aortic root, and many of them go on to have dissection<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p></sec><sec><title>Smoking Habit</title><p>Smoking is a relevant risk factor for AAA. The relative risk of AAA is 7.6
higher in smokers<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Men
who smoke more than 25 cigarettes a day are at 15 times greater risk of
developing AAA contrasted with men who never smoked<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. Smoking presents no less
than a 3.5-fold greater increase in relative risk than any other perceived
AAA risk factor, and the excess prevalence related with smoking is
responsible for 75% of all AAAs 4.0 cm or larger<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p><p>The relationship between smoking and AAA increases significantly with the
number of years of smoking and decreases significantly with the number of
years after smoking has stopped<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. In spite of the fact that discontinuing smoking
is related to a decrease in the risk for AAA, people with a remote history
of smoking still have a higher risk for AAA than people who have never
smoked. The impact of "ever smoking" is believed to be very durable, lasting
decades. The relationship of a background marked by "ever smoking" with the
development of an aortic aneurysm in men is 2.5 times more prominent than
the relationship of "ever smoking" with the development of coronary artery
disease and is 3.5 times more prominent than the relationship of "ever
smoking" with cerebrovascular disease<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>.</p><p>The number of cigarettes smoked every day is relevant, however, the most
critical variable is the time spent smoking<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Every year of smoking increases the
relative risk of AAA by 4% in all populations<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Those that keep on smoking have faster
development of AAA<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>.</p><p>The risk of a smoker developing AAA proceeds for no less than 10 years after
quitting smoking. Nevertheless, to date no causal connection has been
established between smoking and training AAA. The mechanism is independent
of atherosclerosis and hypotheses incorporate interruption in collagen
synthesis, modified expression of metalloproteinases, and reaction to
oxidative stress<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>.</p></sec><sec><title>Chronic Obstructive Pulmonary Disease (COPD)</title><p>An association between COPD and AAA has been reported. The prevalence of AAA
among patients with COPD has been found to be 7% to 11% and most
population-based screening programs report a prevalence of 4% to 6%. The
association has been explained in part as a common degradation of elastic
tissue. Increased elastolytic activity has been described in the serum and
lungs of patients with COPD and in the serum and aorta of patients with
AAA<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p></sec><sec><title>Lipid Levels and Obesity</title><p>The relationship between the levels of plasma lipids and AAA is disputable.
Elevated serum cholesterol levels (&#x0003e; 240 mg/dl) were related with an OR
of 2.82 for AAA (95% CI 2.13 to 3.72)<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>. Be that as it may, a similar retrospective
epidemiological review was unable to duplicate this finding; identifying a
protective effect of elevated levels of HDL in serum<sup>[<xref rid="r35" ref-type="bibr">35</xref>]</sup>. This protective effect
may just be a surrogate marker of cardiovascular wellbeing, as exercise is
known to build HDL cholesterol<sup>[<xref rid="r36" ref-type="bibr">36</xref>]</sup>. The conceivable part of statin treatment to
stabilize the progression of AAA has been investigated. Retrospective
analysis of the Dutch AAA screening database suggested that statins could
moderate AAA development, but this perception has not yet been demonstrated
in a prospective study<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup>.</p><p>Central obesity and AAA are independently associated. Particular
anthropometric measurements, specifically waist circumference (OR 1.14, 95%
CI 1.06 to 1.22) and waist-hip ratio (OR 1.22, 95% CI 1.09 to 1.37) have
been independently associated with AAA in men<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup>. A review has demonstrated that obesity
(BMI &#x0003e; 30 kg/m<sup>2</sup>) was independently associated with AAA (OR
2.0, 95% CI 1.2 to 3.4)<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>.</p></sec><sec><title>Hypertension</title><p>Increased blood pressure is a common risk factor for AAA, yet it has a frail
association<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>.
Hypertension (systolic blood pressure &#x0003e; 160 mmHg, pulmonary artery
diastolic pressure &#x0003e; 95 mmHg) is related with the risk of AAA, though
just in women<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Normal
hypertension has been referred to as an independent risk factor for aneurysm
rupture in men and women. It mirrors the constant hemodynamic load on the
aortic wall, which adds to the brittleness of the arterial wall<sup>[<xref rid="r40" ref-type="bibr">40</xref>]</sup>.</p></sec><sec><title>Diabetes</title><p>Diabetes is a risk factor for atherosclerosis, however, it appears to be
protective against the development of AAA<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. A meta-analysis suggested a reduced rate
of AAA among diabetes patients contrasted with patients without diabetes (OR
0.65, 95% CI 0.6-0.7, <italic>P</italic>&#x0003c;0.00<sup>[<xref rid="r41" ref-type="bibr">41</xref>]</sup>. Diabetes is additionally connected with
a slower growth rate in AAA<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p><p>The proposed components for the protective effect of diabetes comprise
hyperinsulinemia, hyperglycemia, and results of therapeutic agents used to
treat diabetes. These agents may balance out mural thrombus, augment the
stiffness of the aortic wall, and decrease systemic inflammation<sup>[<xref rid="r42" ref-type="bibr">42</xref>]</sup> (<xref ref-type="table" rid="t1">Table 1</xref>)<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Independent risk factors for AAA &#x02265; 4 cm.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Risk Factor</th><th align="center" rowspan="1" colspan="1">Odds Ratio</th><th align="center" rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Increased Risk</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Smoking
history</td><td align="center" rowspan="1" colspan="1">5.1</td><td align="center" rowspan="1" colspan="1">4.1-6.2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Family history
of AAA</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">1.6-2.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Older age (per
7-year interval)</td><td align="center" rowspan="1" colspan="1">1.7</td><td align="center" rowspan="1" colspan="1">1.6-1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Coronary artery
disease</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.4-1.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;High
cholesterol</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">1.3-1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;COPD</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.1-1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Height (per
7-cm interval)</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.1-1.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Decreased Risk</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Abdominal
imaging within 5 years</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">0.7-0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Deep venous
thrombosis</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">0.5-0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diabetes
mellitus</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.5-0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black race</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.4-0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Female
gender</td><td align="center" rowspan="1" colspan="1">0.2</td><td align="center" rowspan="1" colspan="1">0.1-0.5</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AAA=abdominal aortic aneurysm; COPD=chronic obstructive pulmonary
disease</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Pathophysiology of Abdominal Aortic Aneurysm</title><p>The aorta is made out of three layers: the intima, tunica media, and
adventitia. The inward layer is the innermost wall of the aorta, comprised
of endothelial cells in direct contact with the blood. These cells can add
to the formation of the aneurysm by generating reactive oxygen species.</p><p>The middle layer contains extracellular connective components (elastin,
collagen types I and III, and proteoglycans) and SMCs composed of lamellar
functional units. These units, which form the primary load-bearing structure
of the healthy aorta, are depleted significantly over years or decades in
the pathogenesis of AAA. In advanced stages of the disease, the rigidity of
the aorta and the collagen load are dramatically increased due to the
degradations of elastin. The failure happens when the residual collagen
fibers, newly synthesized from the media and adventitia, cannot maintain
structural integrity. The exact succession of events that prompt rupture has
yet to be identified, though it unquestionably includes inflammation and
proteolysis of the middle layer, leading to significant reductions in wall
tensile strength<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup>.</p><p>The adventitia is made out of interstitial collagen, fibroblasts, nerve
fibers and vasa vasorum, being effectively required in the pathogenesis of
AAA. The density of the vasa vasorum diminishes along the length of the
aorta from the aortic root to the bifurcation<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup>. For a considerable length of time, there
has been speculation about a potential connection between the reduced
density of vasa vasorum in the adventitia and the upward trend of formation
of aneurysm in the distal aorta. Nevertheless, evidence of causal connection
between aneurysm development and regional differences in the vascularization
of the adventitia of the aorta remains uncertain. As of late, expanded
inflammationdriven neovascularization has been perceived in surgical
specimens acquired at the time of aneurysm repair, found more prominently in
areas of aortic rupture. In spite of the fact that this neovascularization
is clearly present, it is as yet dubious whether it effectively advances the
movement of aneurysmal sickness with ensuing rupture, or is basically
evidence of progressive wall inflammation<sup>[<xref rid="r45" ref-type="bibr">45</xref>]</sup>.</p><p>The intraluminal thrombus, in addition to being a surrogate marker of illness
progression, can directly intercede in the progression of AAA through
proteolytic activation of matrix metalloproteinases by plasmin. Furthermore,
the aggregation of thrombus may upset the dissemination of oxygen through
the wall of the aorta and result in relative hypoxia potential and
apoptosis/necrosis of SMCs. The laminar thrombus can likewise alter the wall
voltage peak in the AAA. The impact of having a thrombus in the AAA remains
unclear, yet most examiners concur that the laminar thrombus by and large
expands the progression of the disease and the risk of AAA rupture of
comparable diameter<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup>
(<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig.1</label><caption><p>Schematic representation of the impact of the blood-chronic
intraluminal thrombus interface on medial degradation and the
adventitial inflammatory, angiogenic and fibrotic responses in
human AAA. Abbreviations: ATLO, adventitial tertiary lymphoid
organ; and RBCs, red blood cells.</p></caption><graphic xlink:href="rbccv-32-03-0215-g01"/></fig>
</p><p>Matrix metalloproteinases (MMPs) constitute an arrangement of extracellular
enzymes that degrade the cellular matrix, which is essential to an
assortment of physiological processes, including homeostasis, wound healing,
and tissue remodeling and resorption. All MMPs are parts of amino acid
sequences that are considerably similar, containing an essential zinc ion to
its enzyme activity and being inhibited by chelating agents. In addition,
their inhibition in vivo happens through expression and local release of
biological inhibitors of metalloproteinase activity or tissues by
metalloproteinase inhibitors (TIMPs). Pro-MMPs are emitted by neutrophils,
macrophages, fibroblasts, and SMCs. Activation and cleavage of the enzyme
are catalyzed by extracellular proteases, such as, for example, plasmin,
plasminogen activators, and other MMPs<sup>[<xref rid="r47" ref-type="bibr">47</xref>]</sup>.</p><p>MMP-9, otherwise called gelatinase B or 92 kDa gelatinase, severs elastin,
collagen types I and IV, and fibrinogen. AAA disease presents higher MMP-9
plasma levels, and more MMP9 mRNA is available in the aneurysmal aortic
tissue than in the typical aortic tissue. Patients with AAA of intermediate
size (5 to 6.9 cm) present higher serum levels than patients with AAAs
smaller than 4 cm or more prominent than 7 cm. Even though these outcomes
not normalized for the volume of tissue or wall cellularity, a significant
role for MMP-9 activity in disease progression can be inferred<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>. MMP-9 levels reliably
diminish after AAA repair, both endovascular and open, and patients who
continue to have high levels of MMP-9 after endovascular repair of aneurysm
might be at a greater risk of developing and maintaining leaks<sup>[<xref rid="r49" ref-type="bibr">49</xref>]</sup>.</p><p>MMP-2, like MMP-9, cleaves elastin and type IV collagen. Samples taken from
aortic aneurysms demonstrate that MMP-2 activity is relatively lower than
that of MMP-9, which suggests that expansion in MMP-2 activity could mean an
early event in the temporal evolution of AAA pathogenesis. Trial data
indicate that both MMP-2 and MMP-9 should be available and active for
maximum progression of the aneurysm, suggesting a synergistic and
co-dependent relationship between no less than two of the most essential
proteases active in AAA disease<sup>[<xref rid="r50" ref-type="bibr">50</xref>]</sup>.</p><p>Moreover, depletion of SMCs is a distinct pathological characteristic of
advanced aneurysmal disease. During surgical repair, aneurysmal specimens,
contrary to specimens from occlusive aortic diseases, show evidence of
increased apoptosis of SMCs, including higher production of p53. The other
SMCs, albeit viable, show reduced capacity for proliferation. SMCs depletion
is additionally a sentinel feature of experimental aneurysm pathogenesis. A
large number of experimental models have demonstrated the capacity of
enhanced medial cellularity to balance out the integrity of the aorta and
limit the growth of the aneurysm<sup>[<xref rid="r51" ref-type="bibr">51</xref>]</sup>.</p><p>Besides proteolysis and loss of medial cellularity, inflammation is a main
pathophysiological feature of aortic aneurysm ailment. While the starting
events in human AAA sickness remain unclear, there is experimental evidence
indicating that elastin degradation products, or hydrophilic peptides
discharged from events, stimulate and enlarge the location and activation of
mononuclear cells inside the aortic wall. Elastin degradation products bind
to surface proteins and provide stimulus to increase chemotaxis,
phagocytosis, and activation of mononuclear cells. Patients with AAA have
high serum concentrations of elastin degradation products, which is
associated with the risk for sickness progression<sup>[<xref rid="r52" ref-type="bibr">52</xref>]</sup>.</p><p>Production of superoxide (O<sub>2</sub>-) and hydrogen peroxide
(H<sub>2</sub>O<sub>2</sub>) by fibroblasts, constitutive aortic cells,
and infiltrating leukocytes are examples of other early events of
pro-inflammatory signaling. Higher production of these reactive oxygen
species inhibits plasminogen activator inhibitor-1, an enzyme that limits
MMP activation, and prompts increased proteolysis and degradation of the
matrix. Compared to normal aortic tissue, AAA surgical specimens show
considerably higher levels of oxidative stress<sup>[<xref rid="r53" ref-type="bibr">53</xref>]</sup>.</p><p>Inflammatory cells found in AAA surgical specimens incorporate macrophages
and Th1, Th2 and B lymphocytes. There is substantial discussion about the
likely differential role of Th1 and Th2 cells in mediation of aortic
diseases. Despite having an overlap, recent evidence shows that Th2
cytokines responses prevail in AAA disease and that the Th1 cytokine
response is normal for atherosclerotic vascular occlusive infections. Th2
lymphocytes produce interleukin-4 (IL - 4), IL - 5, IL-8 and IL - 10, which
together promote wall angiogenesis, extra release of proinflammatory
cytokines and apoptosis of SMCs by means of the activation of the Fas
ligand. CD4+ T cells, helper T cells with receptor affinity for class II
major histocompatibility complex that produce interferon - &#x003b3;, are the
lymphocytes most commonly found in the aortic aneurysm tissue. Mice with
CD4+ T cells deficiency are impervious to the development of AAA, however,
the reaction could be partially reestablished by exogenous treatment with
interferon &#x003b3;, while AAA formation in interferon &#x003b3; deficient
mice can be reconstituted by reinfusion of wild-type splenocytes<sup>[<xref rid="r54" ref-type="bibr">54</xref>]</sup>.</p><p>Numerous inflammatory responses in SMCs and macrophages incorporate kinase
activation via N-terminal (JNK), otherwise called protein kinase activated
by stress. JNK, a proximal signaling molecule, regulates proteolytic
functions and manufactured vascular SMCs, in addition to pro-inflammatory
cytokine production and proteolytic action of macrophages. To some extent,
JNK activity is responsible for regulating production and activation of more
than 20 proteins significant to the pathogenesis of AAA, including MMP-9 and
IL-1a. JNK expression is expanded in test studies and AAA human tissue
samples<sup>[<xref rid="r55" ref-type="bibr">55</xref>]</sup>.</p><p>Proteins traditionally connected with thrombosis and coagulation cascade
regulation can likewise take part in the pathogenesis of AAA. One study
stated that patients with aortic aneurysms had, on average, three times the
protein C and activated protein C inhibitor than controls. Activated Protein
C/ Protein inhibitor levels correlate with AAA diameter. Additionally,
osteopontin, a pluripotent mediator of bone metabolism, inflammation and
vascular calcification, may be significant in AAA. Serum and tissue
osteopontin concentrations are higher in human disease, and osteopontin
deficient mice demonstrate lessened AAA formation in experimental
models<sup>[<xref rid="r56" ref-type="bibr">56</xref>]</sup>.</p></sec></sec><sec><title>MicroRNAs and the Formation of Aneurysms</title><p>MicroRNAs (miRNA) are single stranded RNA molecules of about 17-23 nucleotides in
length, that act on the regulation of gene expression, and are involved in many
cellular processes, including proliferation, differentiation and
apoptosis<sup>[<xref rid="r57" ref-type="bibr">57</xref>]</sup>.
Evolutionarily, its origin is of the vegetable kingdom as a way of protecting
the genetic material from outside interference. The first small RNA noncoding
identified was the lin-4, control gene regulator lin-14 larval growth,
Caenorhabditis elegans roundworm<sup>[<xref rid="r58" ref-type="bibr">58</xref>]</sup>.</p><p>The process of miRNA biogenesis is complex and involves nuclear and cytoplasmic
components<sup>[<xref rid="r59" ref-type="bibr">59</xref>]</sup>.
Initially, miRNAs are produced in the form of a long primary transcript
(pri-miRNA), several kilobases long, by RNA polymerase II. The pri-miRNA is
processed further in the core by an RNase III endonuclease, known as Drosha,
together with its cofactor Pasha, generating a mature miRNA precursor molecule
termed pre-miRNA, with about 70 nucleotides. Then, the pre-miRNA is transported
to the cytoplasm by exportin-5, using GTP as a cofactor.</p><p>In the cytoplasm, the pre-miRNA is processed by another RNase III, Dicer,
generating a double stranded miRNA of about 22 nucleotides. This product is
incorporated into the RISC multiprotein complex (RNA-induced silencing complex),
whose main components are Argonaut proteins. The helicase activity causes only
one of the miRNA duplex tapes to remain in the RISC complex to control
post-transcriptional expression of target genes<sup>[<xref rid="r60" ref-type="bibr">60</xref>]</sup> (<xref ref-type="fig" rid="f2">Figure
2</xref>)<sup>[<xref rid="r61" ref-type="bibr">61</xref>]</sup>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>A general model of miRNA biogenesis and function.</p></caption><graphic xlink:href="rbccv-32-03-0215-g02"/></fig>
</p><p>MiRNAs traditionally are a class of negative regulators of gene transcription.
Each miRNA may be used for bioinformatics predictions, regular to 300 different
genes, according to the complementary miRNA and mRNA gene sequence<sup>[<xref rid="r62" ref-type="bibr">62</xref>]</sup>. MiRNAs are known for two
mechanisms of action: mRNA degradation and inhibition of their translation. The
first mechanism occurs when there is perfect pairing between the miRNA and the
target gene or when the imperfect matching results in degradation of
mRNA<sup>[<xref rid="r63" ref-type="bibr">63</xref>]</sup>. The
imperfect matching can interfere with the inhibition of translation through boot
lock, removal of ribosomes and elongation inhibition<sup>[<xref rid="r64" ref-type="bibr">64</xref>]</sup>.</p><p>Experiments with specific SMCs emphasize the importance of miRNAs for homeostasis
of vascular SMCs <sup>[<xref rid="r65" ref-type="bibr">65</xref>]</sup>, and it
is likely that miRNAs also play a role in aneurysm formation, which is
characterized by dysfunction of vascular SMCs. Indeed, it has recently been
shown that miRNA-29 plays a key role in the formation of aneurysms<sup>[<xref rid="r66" ref-type="bibr">66</xref>]</sup>.</p><p>These studies have reported that inhibition of miRNA-29 reduces the formation of
aneurysms in various murine models. Specifically, inhibition of all miRNA-29
family has been shown to prevent angiotensin II and induce dilatation of the
aorta in wild type mice<sup>[<xref rid="r66" ref-type="bibr">66</xref>]</sup>.
miRNA-29b inhibitor reduced the progression of aneurysm in an elastase infusion
model in porcine pancreatic C57BL6 mice and, to a lesser extent, in the
angiotensin II infusion model in ApoE <sup>- / -</sup> mice<sup>[<xref rid="r67" ref-type="bibr">67</xref>]</sup>.</p><p>Similar results have been demonstrated in models using mice with genetic
Marfan<sup>(Fbn1C1039G /+)</sup>, in which miRNA-29b locking prevented the
development of aneurysm and apoptosis of the aortic wall<sup>[<xref rid="r68" ref-type="bibr">68</xref>]</sup>. Furthermore, increased
expression of miRNA-29 induced severe aneurysm expansion in two different murine
models<sup>[<xref rid="r67" ref-type="bibr">67</xref>]</sup>.</p><p>All these studies indicate the same molecular mechanism: miRNA-29 regulates
multiple target levels of expression with a role in extracellular matrix, and
therapeutic inhibition of miR-29 improves the structure and integrity of the
vessel wall. It has been previously demonstrated that, in the heart, miRNA-29
acts on different targets of the extracellular matrix, such as collagen and
elastin. These extracellular matrix components are also induced after inhibition
of miRNA-29 in the vasculature<sup>[<xref rid="r66" ref-type="bibr">66</xref>]</sup>. Interestingly, inhibition of miRNA-29 can also be used to
increase elastin expression in patients with insufficient haploidentical cells
as well as elastin deposition in bioengineering vessels<sup>[<xref rid="r60" ref-type="bibr">60</xref>]</sup>. Besides acting on the
structural components of the extracellular matrix, miRNA-29 also targets
anti-apoptotic MCL-1 protein and, paradoxically, MMP-2. In fact, a decrease in
MCL-1 protein was found in mice with Marfan, and inhibition of miRNA-29
prevented apoptosis, which may contribute to the therapeutic effects of
inhibition of miRNA-29<sup>[<xref rid="r68" ref-type="bibr">68</xref>]</sup>.</p><p>In human aneurysms, miRNA-29b (but not miRNA-29a and miRNA-29c) showed high
expression in thoracic aneurysms in one study whereas, in another study, it was
not regulated and showed low expression in abdominal aortic aneurysms (<xref ref-type="fig" rid="f3">Figure 3</xref>). A recent additional report
describes the association of altered levels miRNA-29 with aneurysm formation in
human thoracic aneurysm zones and, using a bioinformatics approach, miRNA-29 has
been proposed to contribute to aneurysm formation<sup>[<xref rid="r69" ref-type="bibr">69</xref>]</sup> (<xref ref-type="fig" rid="f3">Figure
3</xref>)<sup>[<xref rid="r66" ref-type="bibr">66</xref>,<xref rid="r70" ref-type="bibr">70</xref>]</sup>.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Pathophysiology of abdominal aortic aneurysms. Schematic diagram
illustrating events thought to contribute to the development and
progression of abdominal aortic aneurysms. Injury to the aortic
wall, either as a consequence of or in association with known risk
factors (I), leads to recruitment of leukocytes into the aortic
media (II), macrophage (MPh) activation, and production of
proinflammatory molecules (III). Macrophages also produce proenzyme
forms of matrix metalloproteinases (MMPs) (pro-MMPs) (IV), which are
activated in the extracellular space (V). Tissue inhibitors of
matrix metalloproteinases (TIMPs) may neutralize MMP activity (VI),
but this neutralization appears insufficient to prevent degradation
of structural matrix proteins (elastin and interstitial collagens)
(VII). Over a period of years, elastin degradation, cyclic strain,
and elevated wall tension bring about progressive aortic dilatation
(VIII). Collagen degradation further weakens the aortic wall (IX);
although medial smooth muscle cells (SMCs) and fibroblasts might
promote structural repair, apoptosis, and cellular senescence cause
SMC depletion (X), and interstitial collagen appears disorganized
(XI). Aneurysm tissues exhibit infiltration by T cells, B
lymphocytes, plasma cells, and dendritic cells and local deposition
of immunoglobulins, reflecting a cellular and humoral immune
response (XII). Understanding the adaptive cellular immune response
in abdominal aortic aneurysms may reveal how different T-cell
subsets (i.e., helper T cell type 1 [Th1] versus Th2) interact with
macro- phages to promote or suppress aneurysmal degeneration, on the
basis of the local balance of proinflammatory (XIII) and
anti-inflammatory (XIV) molecules. Some cytokines produced within
aneurysm tissue, such as interleukin-6 (IL-6) and
interferon-&#x003b3; (IFN-&#x003b3;), may have dual and opposing
functions depending on the specific context (XV). The promotion of
miR-29 induces the extracellular matrix degradation and induces the
formation of aneurysms (XVI). EDPs, Elastin degradation peptides;
PGs, prostaglandins; ROS, reactive oxygen species; TGF-&#x003b2;,
transforming growth factor-&#x003b2;; TNF-&#x003b1;, tumor necrosis
factor-&#x003b1;; miR-29, microRNA-29<sup>[<xref rid="r70" ref-type="bibr">70</xref>]</sup>.</p></caption><graphic xlink:href="rbccv-32-03-0215-g03"/></fig>
</p><p>Similar to miRNA-29, other miRNAs have been described to play a role in the
pathogenesis of aneurysm. One of the first reports referring to the role of
miRNAs in the formation of aneurysms describes the mechanism by which
miRNA-143/145 regulates SMCs function. The authors showed that, in human
thoracic aneurysms, miRNA-143 and miRNA-145 were expressed at lower levels in
comparison with healthy thoracic aorta, which correlated with the SMCs function.
Another study points to the role of miRNA-143/145 in the maintenance of SMCs
function and describes the specific elimination of SMCs in rats, leading to
contractile dysfunction of SMCs that can be rescued by restoration of
miRNA-143/145<sup>[<xref rid="r65" ref-type="bibr">65</xref>]</sup>.
Whenever there was restoration of miRNA-143/145, aneurysm formation was not
reported. Another major regulator of vascular smooth muscle phenotype cells,
miRNA-21 was shown to inhibit the formation of aneurysms in rats. Overexpression
of miRNA-21 protected against progression of the aneurysm while inhibition of
miRNA-21 further increased the current aneurysm formation<sup>[<xref rid="r66" ref-type="bibr">66</xref>]</sup>.</p></sec><sec><title>Risk of Rupture</title><p>Several factors are associated with AAA rupture. The most commonly used indicator
of AAA rupture is the maximum diameter of the aneurysm (<xref ref-type="table" rid="t2">Table 2</xref>)<sup>[<xref rid="r71" ref-type="bibr">71</xref>]</sup>. Significant AAA diameter at break was 5 cm in women and 6
cm in men. After adjusting for age, initial AAA diameter, height, and BMI, the
AAA rupture rate was three times higher in women than in men. Therefore,
diameter limits AAA<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Estimated annual rupture risk.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">AAA diameter (cm)</th><th align="center" rowspan="1" colspan="1">Rupture risk (%/y)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">&#x0003c; 4</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">4 &#x02013; 5</td><td align="center" rowspan="1" colspan="1">0.5 &#x02013; 5</td></tr><tr><td align="center" rowspan="1" colspan="1">5 &#x02013; 6</td><td align="center" rowspan="1" colspan="1">3 &#x02013; 15</td></tr><tr><td align="center" rowspan="1" colspan="1">6 &#x02013; 7</td><td align="center" rowspan="1" colspan="1">10 &#x02013; 20</td></tr><tr><td align="center" rowspan="1" colspan="1">7 &#x02013; 8</td><td align="center" rowspan="1" colspan="1">20 &#x02013; 40</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003e; 8</td><td align="center" rowspan="1" colspan="1">30 &#x02013; 50</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>AAA=abdominal aortic aneurysm</p></fn></table-wrap-foot></table-wrap><p>Studies with biomarkers and biomechanics were investigated for their usefulness
in predicting AAA rupture and, although specific finite element programs are
promising, these techniques are not sufficiently specific to be applied in
clinical practice<sup>[<xref rid="r72" ref-type="bibr">72</xref>]</sup>. Studies
examining putative biomarkers for AAA rupture are scarce and have focused on
plasma proteins sensitive to inflammation, such as fibrinogen and
&#x003b1;-1-antitrypsin<sup>[<xref rid="r73" ref-type="bibr">73</xref>]</sup>. Increased levels of these markers are likely to be a
consequence of the rupture rather than a real risk predictor<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>AAA growth was suggested to have an independent effect on the risk of rupture. A
growth greater than 1 cm per year has been used as an independent indication for
AAA surgery<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Other factors
have been shown to be independent and significantly associated with the risk of
AAA rupture, namely: female gender (OR 4.5, 95% CI 1.98 to 10.2), smoking (OR
2.1, 95% CI 0.95 to 4.67), and hypertension (mean blood pressure &#x0003e; 110 mmHg)
(OR 1.04, 95% CI 1.02 to 1.07)<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>. Pharmacological mechanisms to reduce the risk of AAA
rupture have been explored. One study showed that patients taking angiotensin
converting enzyme inhibitors are less likely to present with AAA rupture (OR
0.82, 95% CI 0.74- 9)<sup>[<xref rid="r74" ref-type="bibr">74</xref>]</sup>.</p></sec><sec><title>Treatment and Follow-up</title><p>Once an aneurysm is established, its natural history grows gradually. A clearer
understanding of the AAA pathophysiology led to testing pharmacological
strategies to limit the expansion of the aneurysm. &#x003b2;-blockers and
antibiotics have failed to translate the results in animal studies to therapies
in clinical practice<sup>[<xref rid="r75" ref-type="bibr">75</xref>]</sup>. At
present, surgery is the only proven effective treatment to prevent rupture of
AAA and death related to the aneurysm. This intervention should be carried out
when the AAA reaches 5.5 cm in diameter in male patients and 5 cm in female
patients and in all symptomatic aneurysms, regardless of diameter.</p><p>Initial evidence of the benefit of endovascular aneurysm repair (EVAR) over open
surgery was provided by single-center and registry data. These registries
described 2.9% to 5.8% mortality for elective EVAR and led to randomized
controlled trials comparing established open surgery with endovascular
techniques. Three randomized controlled trials have compared EVAR with open
surgery in patients fit for elective surgery. The EVAR1, DREAM, and OVER trials
have reported medium-term and long-term outcomes. All studies have demonstrated
an early perioperative mortality benefit for EVAR <italic>versus</italic> open
surgery (EVAR1: 1.7% <italic>versus</italic> 4.7%, <italic>P</italic>=0.009;
DREAM: 1.2% <italic>versus</italic> 4.6%, <italic>P</italic>=0.1; OVER: 0.5%
<italic>versus</italic> 3.0%, <italic>P</italic>=0.004). In addition,
patients assigned to EVAR had less blood loss, required fewer blood
transfusions, and had reduced intensive-care stay than patients assigned to open
surgery. However, no difference between the two treatment options was found for
long-term (&#x0003e;2 years) total mortality or AAA-related mortality<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>The uptake of EVAR for elective surgical management of AAA is now approaching 80%
in many centers. In the context of surgical management of a ruptured AAA, a
substantial body of evidence demonstrates improved survival with an EVAR-first
approach<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Leak rates range from 0 to 47%, depending on the type of stent graft, patient
selection, implantation technique and morphology of the aorta. The presence of
leaks can be associated with further expansion of the aneurysm, which in turn
may result in rupture. Thus, it becomes necessary to monitor patients submitted
to endovascular repair of AAAs using computed tomography scans, with a
significant increase in costs of the overall process<sup>[<xref rid="r76" ref-type="bibr">76</xref>]</sup>.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, it can be said that the formation of an aneurysm is a multifactorial
complex process, involving the destructive remodeling of the connective tissue
around the affected segment of the aortic wall. In recent years, considerable effort
has been dedicated to elucidate the molecular mechanisms and AAA training roads,
with recent studies focusing on the role of miRNAs. By understanding the
pathophysiology of aneurysm formation, treatments with specific drugs can be
designed to interrupt the growth of or even to avoid their breakage. The study of
miRNAs and their modulation will add to our understanding of the formation AAA and
may result in potential therapeutic targets.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EEJ</td><td align="left" rowspan="1" colspan="1">Conception and design of the work; final approval of
the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MSR</td><td align="left" rowspan="1" colspan="1">Revising it critically for important intellectual
content; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EJRT</td><td align="left" rowspan="1" colspan="1">Acquisition, analysis, and interpretation of data for
the work; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Department of Surgery and Anatomy, Faculdade de
Medicina de Ribeir&#x000e3;o Preto, Universidade de S&#x000e3;o Paulo (FMRP-USP),
Ribeir&#x000e3;o Preto, SP, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>KW</given-names></name><name><surname>Rutherford</surname><given-names>RB</given-names></name><name><surname>Tilson</surname><given-names>MD</given-names></name><name><surname>Shah</surname><given-names>DM</given-names></name><name><surname>Hollier</surname><given-names>L</given-names></name><name><surname>Stanley</surname><given-names>JC</given-names></name></person-group><article-title>Suggested standards for reporting on arterial aneurysms.
Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee
on Reporting Standards, Society for Vascular Surgery and North American
Chapter, International Society for Cardiovascular Surgery</article-title><source>J Vasc Surg</source><year>1991</year><volume>13</volume><issue>3</issue><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">1999868</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>PE</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name></person-group><article-title>Site specificity of aneurysmal disease</article-title><source>Circulation</source><year>2010</year><volume>121</volume><issue>4</issue><fpage>560</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">20124136</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>AS</given-names></name></person-group><article-title>Aortic aneurysmal disease. A generalized dilating
diathesis</article-title><source>Arch Surg</source><year>1992</year><volume>127</volume><issue>8</issue><fpage>990</fpage><lpage>991</lpage><pub-id pub-id-type="pmid">1642543</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodall</surname><given-names>S</given-names></name><name><surname>Crowther</surname><given-names>M</given-names></name><name><surname>Bell</surname><given-names>PR</given-names></name><name><surname>Thompson</surname><given-names>MM</given-names></name></person-group><article-title>The association between venous structural alterations and
biomechanical weakness in patients with abdominal aortic
aneurysms</article-title><source>J Vasc Surg</source><year>2002</year><volume>35</volume><issue>5</issue><fpage>937</fpage><lpage>942</lpage><pub-id pub-id-type="pmid">12021710</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoeven</surname><given-names>EL</given-names></name><name><surname>Kapma</surname><given-names>MR</given-names></name><name><surname>Groen</surname><given-names>H</given-names></name><name><surname>Tielliu</surname><given-names>IF</given-names></name><name><surname>Zeebregts</surname><given-names>CJ</given-names></name><name><surname>Bekkema</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mortality of ruptured abdominal aortic aneurysm treated with open
or endovascular repair</article-title><source>J Vasc Surg</source><year>2008</year><volume>48</volume><issue>6</issue><fpage>1396</fpage><lpage>1400</lpage><pub-id pub-id-type="pmid">18829222</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindholt</surname><given-names>JS</given-names></name><name><surname>Juul</surname><given-names>S</given-names></name><name><surname>Fasting</surname><given-names>H</given-names></name><name><surname>Henneberg</surname><given-names>EW</given-names></name></person-group><article-title>Screening for abdominal aortic aneurysms: single centre
randomised controlled trial</article-title><source>BMJ</source><year>2005</year><volume>330</volume><issue>7494</issue><fpage>750</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">15757960</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlane</surname><given-names>MJ</given-names></name></person-group><article-title>The epidemiologic necropsy for abdominal aortic
aneurysm</article-title><source>JAMA</source><year>1991</year><volume>265</volume><issue>16</issue><fpage>2085</fpage><lpage>2088</lpage><pub-id pub-id-type="pmid">2013928</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillum</surname><given-names>RF</given-names></name></person-group><article-title>Epidemiology of aortic aneurysm in the United
States</article-title><source>J Clin Epidemiol</source><year>1995</year><volume>48</volume><issue>11</issue><fpage>1289</fpage><lpage>1298</lpage><pub-id pub-id-type="pmid">7490591</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordon</surname><given-names>IM</given-names></name><name><surname>Hinchliffe</surname><given-names>RJ</given-names></name><name><surname>Loftus</surname><given-names>IM</given-names></name><name><surname>Thompson</surname><given-names>MM</given-names></name></person-group><article-title>Pathophysiology and epidemiology of abdominal aortic
aneurysms</article-title><source>Nat Rev Cardiol</source><year>2011</year><volume>8</volume><issue>2</issue><fpage>92</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">21079638</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Bridgewater</surname><given-names>SG</given-names></name><name><surname>Ashton</surname><given-names>HA</given-names></name></person-group><article-title>Randomized clinical trial of screening for abdominal aortic
aneurysm in women</article-title><source>Br J Surg</source><year>2002</year><volume>89</volume><issue>3</issue><fpage>283</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">11872050</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>KC</given-names></name><name><surname>Zwolak</surname><given-names>RM</given-names></name><name><surname>Egorova</surname><given-names>NN</given-names></name><name><surname>Riles</surname><given-names>TS</given-names></name><name><surname>Manganaro</surname><given-names>A</given-names></name><name><surname>Moskowitz</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Analysis of risk factors for abdominal aortic aneurysm in a
cohort of more than 3 million individuals</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>3</issue><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">20630687</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsdahl</surname><given-names>SH</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Solberg</surname><given-names>S</given-names></name><name><surname>Jacobsen</surname><given-names>BK</given-names></name></person-group><article-title>Risk factors for abdominal aortic aneurysms: a 7-year prospective
study: the Troms&#x000f8; Study, 1994-2001</article-title><source>Circulation</source><year>2009</year><volume>119</volume><issue>16</issue><fpage>2202</fpage><lpage>2208</lpage><pub-id pub-id-type="pmid">19364978</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>MK</given-names></name><name><surname>Rayt</surname><given-names>HS</given-names></name><name><surname>Hussey</surname><given-names>G</given-names></name><name><surname>Rafelt</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name><name><surname>Sayers</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Should Asian men be included in abdominal aortic aneurysm
screening programmes?</article-title><source>Eur J Vasc Endovasc Surg</source><year>2009</year><volume>38</volume><issue>6</issue><fpage>748</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">19666232</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>S</given-names></name><name><surname>Ogren</surname><given-names>M</given-names></name><name><surname>Bengtsson</surname><given-names>H</given-names></name><name><surname>Bergqvist</surname><given-names>D</given-names></name><name><surname>Lindblad</surname><given-names>B</given-names></name><name><surname>Zdanowski</surname><given-names>Z</given-names></name></person-group><article-title>Increasing incidence of ruptured abdominal aortic aneurysm: a
population-based study</article-title><source>J Vasc Surg</source><year>2006</year><volume>44</volume><issue>2</issue><fpage>237</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">16890847</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>JF</given-names></name></person-group><article-title>Epidemiology of abdominal aortic aneurysms</article-title><source>Epidemiol Rev</source><year>1999</year><volume>21</volume><issue>2</issue><fpage>207</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">10682258</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Johnson</surname><given-names>GR</given-names></name><name><surname>Wilson</surname><given-names>SE</given-names></name><collab>Aneurysm Detection and Management Veterans Affairs Cooperative
Study</collab></person-group><article-title>Abdominal aortic aneurysm in women</article-title><source>J Vasc Surg</source><year>2001</year><volume>34</volume><issue>1</issue><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">11436084</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosford</surname><given-names>PA</given-names></name><name><surname>Leng</surname><given-names>GC</given-names></name></person-group><article-title>Screening for abdominal aortic aneurysm</article-title><source>Cochrane Database Syst Rev</source><year>2007</year><volume>2</volume><fpage>CD002945</fpage><lpage>CD002945</lpage></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>T</given-names></name><name><surname>MacKean</surname><given-names>GL</given-names></name><name><surname>Cole</surname><given-names>CW</given-names></name><name><surname>Arthur</surname><given-names>C</given-names></name><name><surname>Andreou</surname><given-names>P</given-names></name><name><surname>Tromp</surname><given-names>G</given-names></name><etal/></person-group><article-title>The lifetime prevalence of abdominal aortic aneurysms among
siblings of aneurysm patients is eightfold higher than among siblings of
spouses: an analysis of 187 aneurysm families in Nova Scotia,
Canada</article-title><source>J Vasc Surg</source><year>2005</year><volume>42</volume><issue>5</issue><fpage>891</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">16275443</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Granath</surname><given-names>F</given-names></name><name><surname>Swedenborg</surname><given-names>J</given-names></name><name><surname>Hultgren</surname><given-names>R</given-names></name></person-group><article-title>A population-based case-control study of the familial risk of
abdominal aortic aneurysm</article-title><source>J Vasc Surg</source><year>2009</year><volume>49</volume><issue>1</issue><fpage>47</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">19028058</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astrand</surname><given-names>H</given-names></name><name><surname>Ryd&#x000e9;n-Ahlgren</surname><given-names>A</given-names></name><name><surname>Sundkvist</surname><given-names>G</given-names></name><name><surname>Sandgren</surname><given-names>T</given-names></name><name><surname>L&#x000e4;nne</surname><given-names>T</given-names></name></person-group><article-title>Reduced aortic wall stress in diabetes mellitus</article-title><source>Eur J Vasc Endovasc Surg</source><year>2007</year><volume>33</volume><issue>5</issue><fpage>592</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">17164093</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahlgren</surname><given-names>CM</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Hultgren</surname><given-names>R</given-names></name><name><surname>Swedenborg</surname><given-names>J</given-names></name></person-group><article-title>Genetic and environmental contributions to abdominal aortic
aneurysm development in a twin population</article-title><source>J Vasc Surg</source><year>2010</year><volume>51</volume><issue>1</issue><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19939604</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Aneurysm Consortium</collab></person-group><article-title>Genome Wide Association Studies: identifying the genes that
determine the risk of abdominal aortic aneurysm</article-title><source>Eur J Vasc Endovasc Surg</source><year>2008</year><volume>36</volume><issue>4</issue><fpage>395</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">18621558</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunton</surname><given-names>TE</given-names></name><name><surname>Biery</surname><given-names>NJ</given-names></name><name><surname>Myers</surname><given-names>L</given-names></name><name><surname>Gayraud</surname><given-names>B</given-names></name><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Dietz</surname><given-names>HC</given-names></name></person-group><article-title>Phenotypic alteration of vascular smooth muscle cells precedes
elastolysis in a mouse model of Marfan syndrome</article-title><source>Circ Res</source><year>2001</year><volume>88</volume><issue>1</issue><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11139471</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepin</surname><given-names>M</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Superti-Furga</surname><given-names>A</given-names></name><name><surname>Byers</surname><given-names>PH</given-names></name></person-group><article-title>Clinical and genetic features of Ehlers-Danlos syndrome type IV,
the vascular type</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>10</issue><fpage>673</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">10706896</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuivaniemi</surname><given-names>H</given-names></name><name><surname>Platsoucas</surname><given-names>CD</given-names></name><name><surname>Tilson 3rd</surname><given-names>MD</given-names></name></person-group><article-title>Aortic aneurysms: an immune disease with a strong genetic
component</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>2</issue><fpage>242</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">18195185</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeys</surname><given-names>BL</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Holm</surname><given-names>T</given-names></name><name><surname>Callewaert</surname><given-names>BL</given-names></name><name><surname>Thomas</surname><given-names>GH</given-names></name><name><surname>Pannu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Aneurysm syndromes caused by mutations in the TGF-beta
receptor</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><issue>8</issue><fpage>788</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">16928994</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmink</surname><given-names>TB</given-names></name><name><surname>Quick</surname><given-names>CR</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name></person-group><article-title>The association between cigarette smoking and abdominal aortic
aneurysms</article-title><source>J Vasc Surg</source><year>1999</year><volume>30</volume><issue>6</issue><fpage>1099</fpage><lpage>1105</lpage><pub-id pub-id-type="pmid">10587395</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DR</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name></person-group><article-title>Smoking, hypertension, alcohol consumption, and risk of abdominal
aortic aneurysm in men</article-title><source>Am J Epidemiol</source><year>2007</year><volume>165</volume><issue>7</issue><fpage>838</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">17215382</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Johnson</surname><given-names>GR</given-names></name><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Chute</surname><given-names>EP</given-names></name><name><surname>Littooy</surname><given-names>FN</given-names></name><name><surname>Bandyk</surname><given-names>D</given-names></name><etal/></person-group><article-title>Prevalence and associations of abdominal aortic aneurysm detected
through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs
Cooperative Study Group</article-title><source>Ann Intern Med</source><year>1997</year><volume>126</volume><issue>6</issue><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">9072929</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Johnson</surname><given-names>GR</given-names></name><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Littooy</surname><given-names>FN</given-names></name><name><surname>Krupski</surname><given-names>WC</given-names></name><name><surname>Bandyk</surname><given-names>D</given-names></name><etal/></person-group><article-title>Yield of repeated screening for abdominal aortic aneurysm after a
4-year interval. Aneurysm Detection and Management Veterans Affairs
Cooperative Study Investigators</article-title><source>Arch Intern Med</source><year>2000</year><volume>160</volume><issue>8</issue><fpage>1117</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">10789604</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Nelson</surname><given-names>DB</given-names></name><name><surname>Joseph</surname><given-names>AM</given-names></name></person-group><article-title>Smokers' relative risk for aortic aneurysm compared with other
smoking-related diseases: a systematic review</article-title><source>J Vasc Surg</source><year>2003</year><volume>38</volume><issue>2</issue><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">12891116</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacSweeney</surname><given-names>ST</given-names></name><name><surname>Ellis</surname><given-names>M</given-names></name><name><surname>Worrell</surname><given-names>PC</given-names></name><name><surname>Greenhalgh</surname><given-names>RM</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name></person-group><article-title>Smoking and growth rate of small abdominal aortic
aneurysms</article-title><source>Lancet</source><year>1994</year><volume>344</volume><issue>8923</issue><fpage>651</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">7915350</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knuutinen</surname><given-names>A</given-names></name><name><surname>Kokkonen</surname><given-names>N</given-names></name><name><surname>Risteli</surname><given-names>J</given-names></name><name><surname>V&#x000e4;h&#x000e4;kangas</surname><given-names>K</given-names></name><name><surname>Kallioinen</surname><given-names>M</given-names></name><name><surname>Salo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Smoking affects collagen synthesis and extracellular matrix
turnover in human skin</article-title><source>Br J Dermatol</source><year>2002</year><volume>146</volume><issue>4</issue><fpage>588</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">11966688</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iribarren</surname><given-names>C</given-names></name><name><surname>Darbinian</surname><given-names>JA</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Fireman</surname><given-names>BH</given-names></name><name><surname>Lee</surname><given-names>CD</given-names></name><name><surname>Grey</surname><given-names>DP</given-names></name></person-group><article-title>Traditional and novel risk factors for clinically diagnosed
abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort
study</article-title><source>Ann Epidemiol</source><year>2007</year><volume>17</volume><issue>9</issue><fpage>669</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">17512215</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleumeekers</surname><given-names>HJ</given-names></name><name><surname>Hoes</surname><given-names>AW</given-names></name><name><surname>van der Does</surname><given-names>E</given-names></name><name><surname>van Urk</surname><given-names>H</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Jong</surname><given-names>PT</given-names></name><etal/></person-group><article-title>Aneurysms of the abdominal aorta in older adults. The Rotterdam
Study</article-title><source>Am J Epidemiol</source><year>1995</year><volume>142</volume><issue>12</issue><fpage>1291</fpage><lpage>1299</lpage><pub-id pub-id-type="pmid">7503049</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagiv</surname><given-names>M</given-names></name><name><surname>Goldbourt</surname><given-names>U</given-names></name></person-group><article-title>Influence of physical work on high density lipoprotein
cholesterol: implications for the risk of coronary heart
disease</article-title><source>Int J Sports Med</source><year>1994</year><volume>15</volume><issue>5</issue><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">7960321</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schouten</surname><given-names>O</given-names></name><name><surname>van Laanen</surname><given-names>JH</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Vidakovic</surname><given-names>R</given-names></name><name><surname>Feringa</surname><given-names>HH</given-names></name><name><surname>Dunkelgr&#x000fc;n</surname><given-names>M</given-names></name><etal/></person-group><article-title>Statins are associated with a reduced infrarenal abdominal aortic
aneurysm growth</article-title><source>Eur J Vasc Endovasc Surg</source><year>2006</year><volume>32</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">16520071</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanhainen</surname><given-names>A</given-names></name><name><surname>Bergqvist</surname><given-names>D</given-names></name><name><surname>Boman</surname><given-names>K</given-names></name><name><surname>Nilsson</surname><given-names>TK</given-names></name><name><surname>Ruteg&#x000e5;rd</surname><given-names>J</given-names></name><name><surname>Bj&#x000f6;rck</surname><given-names>M</given-names></name></person-group><article-title>Risk factors associated with abdominal aortic aneurysm: a
population-based study with historical and current data</article-title><source>J Vasc Surg</source><year>2005</year><volume>41</volume><issue>3</issue><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">15838468</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>A</given-names></name><name><surname>Bui</surname><given-names>HT</given-names></name><name><surname>Barbe</surname><given-names>C</given-names></name><name><surname>Henni</surname><given-names>AH</given-names></name><name><surname>Journet</surname><given-names>J</given-names></name><name><surname>Metz</surname><given-names>D</given-names></name><etal/></person-group><article-title>Prevalence of abdominal aortic aneurysm and large infrarenal
aorta in patients with acute coronary syndrome and proven coronary stenosis:
a prospective monocenter study</article-title><source>Ann Vasc Surg</source><year>2010</year><volume>24</volume><issue>5</issue><fpage>602</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">20371161</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>LC</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name></person-group><article-title>Risk factors for aneurysm rupture in patients kept under
ultrasound surveillance. UK Small Aneurysm Trial
Participants</article-title><source>Ann Surg</source><year>1999</year><volume>230</volume><issue>3</issue><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">10493476</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golledge</surname><given-names>J</given-names></name><name><surname>Clancy</surname><given-names>P</given-names></name><name><surname>Jamrozik</surname><given-names>K</given-names></name><name><surname>Norman</surname><given-names>PE</given-names></name></person-group><article-title>Obesity, adipokines, and abdominal aortic aneurysm: Health in Men
study</article-title><source>Circulation</source><year>2007</year><volume>116</volume><issue>20</issue><fpage>2275</fpage><lpage>2279</lpage><pub-id pub-id-type="pmid">17967974</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shantikumar</surname><given-names>S</given-names></name><name><surname>Ajjan</surname><given-names>R</given-names></name><name><surname>Porter</surname><given-names>KE</given-names></name><name><surname>Scott</surname><given-names>DJ</given-names></name></person-group><article-title>Diabetes and the abdominal aortic aneurysm</article-title><source>Eur J Vasc Endovasc Surg</source><year>2010</year><volume>39</volume><issue>2</issue><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">19948418</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golledge</surname><given-names>J</given-names></name><name><surname>Karan</surname><given-names>M</given-names></name><name><surname>Moran</surname><given-names>CS</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Clancy</surname><given-names>P</given-names></name><name><surname>Dear</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Reduced expansion rate of abdominal aortic aneurysms in patients
with diabetes may be related to aberrant monocyte-matrix
interactions</article-title><source>Eur Heart J</source><year>2008</year><volume>29</volume><issue>5</issue><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">18263873</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolinsky</surname><given-names>H</given-names></name><name><surname>Glagov</surname><given-names>S</given-names></name></person-group><article-title>A lamellar unit of aortic medial structure and function in
mammals</article-title><source>Circ Res</source><year>1967</year><volume>20</volume><issue>1</issue><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">4959753</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrin</surname><given-names>PB</given-names></name></person-group><article-title>Pathophysiology and pathogenesis of aortic aneurysms. Current
concepts</article-title><source>Surg Clin North Am</source><year>1989</year><volume>69</volume><issue>4</issue><fpage>687</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">2665139</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choke</surname><given-names>E</given-names></name><name><surname>Cockerill</surname><given-names>GW</given-names></name><name><surname>Dawson</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>RW</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Loftus</surname><given-names>IM</given-names></name><etal/></person-group><article-title>Increased angiogenesis at the site of abdominal aortic aneurysm
rupture</article-title><source>Ann N Y Acad Sci</source><year>2006</year><volume>1085</volume><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">17182949</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>JB</given-names></name><name><surname>Martin-Ventura</surname><given-names>JL</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Sakalihasan</surname><given-names>N</given-names></name><name><surname>Treska</surname><given-names>V</given-names></name><name><surname>Lindholt</surname><given-names>J</given-names></name><etal/></person-group><article-title>Novel aspects of the pathogenesis of aneurysms of the abdominal
aorta in humans</article-title><source>Cardiovasc Res</source><year>2011</year><volume>90</volume><issue>1</issue><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">21037321</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMillan</surname><given-names>WD</given-names></name><name><surname>Tamarina</surname><given-names>NA</given-names></name><name><surname>Cipollone</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>DA</given-names></name><name><surname>Parker</surname><given-names>MA</given-names></name><name><surname>Pearce</surname><given-names>WH</given-names></name></person-group><article-title>Size matters: the relationship between MMP-9 expression and
aortic diameter</article-title><source>Circulation</source><year>1997</year><volume>96</volume><issue>7</issue><fpage>2228</fpage><lpage>2232</lpage><pub-id pub-id-type="pmid">9337194</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorelli</surname><given-names>DR</given-names></name><name><surname>Jean-Claude</surname><given-names>JM</given-names></name><name><surname>Fox</surname><given-names>CJ</given-names></name><name><surname>Clyne</surname><given-names>J</given-names></name><name><surname>Cambria</surname><given-names>RA</given-names></name><name><surname>Seabrook</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Response of plasma matrix metalloproteinase-9 to conventional
abdominal aortic aneurysm repair or endovascular exclusion: implications for
endoleak</article-title><source>J Vasc Surg</source><year>2002</year><volume>35</volume><issue>5</issue><fpage>916</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">12021707</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>GM</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Greiner</surname><given-names>TC</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Fiotti</surname><given-names>N</given-names></name><name><surname>Baxter</surname><given-names>BT</given-names></name></person-group><article-title>Matrix metalloproteinases 2 and 9 work in concert to produce
aortic aneurysms</article-title><source>J Clin Invest</source><year>2002</year><volume>110</volume><issue>5</issue><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">12208863</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowther</surname><given-names>M</given-names></name><name><surname>Goodall</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>JL</given-names></name><name><surname>Bell</surname><given-names>PR</given-names></name><name><surname>Thompson</surname><given-names>MM</given-names></name></person-group><article-title>Increased matrix metalloproteinase 2 expression in vascular
smooth muscle cells cultured from abdominal aortic aneurysms</article-title><source>J Vasc Surg</source><year>2000</year><volume>32</volume><issue>3</issue><fpage>575</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">10957667</pub-id></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindholt</surname><given-names>JS</given-names></name></person-group><article-title>Activators of plasminogen and the progression of small abdominal
aortic aneurysms</article-title><source>Ann N Y Acad Sci</source><year>2006</year><volume>1085</volume><fpage>139</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">17182930</pub-id></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>FJ</given-names><suffix>Jr</suffix></name><name><surname>Sharp</surname><given-names>WJ</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Oberley</surname><given-names>LW</given-names></name><name><surname>Oberley</surname><given-names>TD</given-names></name><name><surname>Weintraub</surname><given-names>NL</given-names></name></person-group><article-title>Oxidative stress in human abdominal aortic aneurysms: a potential
mediator of aneurysmal remodeling</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><issue>4</issue><fpage>560</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">11950691</pub-id></element-citation></ref><ref id="r54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Prall</surname><given-names>A</given-names></name><name><surname>Greiner</surname><given-names>TC</given-names></name><name><surname>Baxter</surname><given-names>BT</given-names></name></person-group><article-title>Key roles of CD4+ T cells and IFN-gamma in the development of
abdominal aortic aneurysms in a murine model</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><issue>4</issue><fpage>2607</fpage><lpage>2612</lpage><pub-id pub-id-type="pmid">14764734</pub-id></element-citation></ref><ref id="r55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>K</given-names></name><name><surname>Aoki</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Fujii</surname><given-names>K</given-names></name><name><surname>Akiyama</surname><given-names>N</given-names></name><name><surname>Furutani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Regression of abdominal aortic aneurysm by inhibition of c-Jun
N-terminal kinase</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><issue>12</issue><fpage>1330</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">16311603</pub-id></element-citation></ref><ref id="r56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;lbel</surname><given-names>T</given-names></name><name><surname>Strandberg</surname><given-names>K</given-names></name><name><surname>Donath</surname><given-names>T</given-names></name><name><surname>Mattiasson</surname><given-names>I</given-names></name><name><surname>Stenflo</surname><given-names>J</given-names></name><name><surname>Lindblad</surname><given-names>B</given-names></name></person-group><article-title>Activated protein C-protein C inhibitor complex in patients with
abdominal aortic aneurysms: is it associated with diameter and growth
rate?</article-title><source>Vasc Endovascular Surg</source><year>2008</year><volume>42</volume><issue>2</issue><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">18184931</pub-id></element-citation></ref><ref id="r57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynam-Lennon</surname><given-names>N</given-names></name><name><surname>Maher</surname><given-names>SG</given-names></name><name><surname>Reynolds</surname><given-names>JV</given-names></name></person-group><article-title>The roles of microRNA in cancer and apoptosis</article-title><source>Biol Rev Camb Philos Soc</source><year>2009</year><volume>84</volume><issue>1</issue><fpage>55</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">19046400</pub-id></element-citation></ref><ref id="r58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>RC</given-names></name><name><surname>Feinbaum</surname><given-names>RL</given-names></name><name><surname>Ambros</surname><given-names>V</given-names></name></person-group><article-title>The C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14</article-title><source>Cell</source><year>1993</year><volume>75</volume><issue>5</issue><fpage>843</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">8252621</pub-id></element-citation></ref><ref id="r59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name><name><surname>Alvarez-Saavedra</surname><given-names>E</given-names></name><name><surname>Lamb</surname><given-names>J</given-names></name><name><surname>Peck</surname><given-names>D</given-names></name><etal/></person-group><article-title>MicroRNA expression profiles classify human
cancers</article-title><source>Nature</source><year>2005</year><volume>435</volume><issue>7043</issue><fpage>834</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">15944708</pub-id></element-citation></ref><ref id="r60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Dahlberg</surname><given-names>JE</given-names></name><name><surname>Tam</surname><given-names>W</given-names></name></person-group><article-title>MicroRNAs in tumorigenesis: a primer</article-title><source>Am J Pathol</source><year>2007</year><volume>171</volume><issue>3</issue><fpage>728</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">17724137</pub-id></element-citation></ref><ref id="r61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kai</surname><given-names>ZS</given-names></name><name><surname>Pasquinelli</surname><given-names>AE</given-names></name></person-group><article-title>MicroRNA assassins: factors that regulate the disappearance of
miRNAs</article-title><source>Nat Struct Mol Biol</source><year>2010</year><volume>17</volume><issue>1</issue><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">20051982</pub-id></element-citation></ref><ref id="r62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>SD</given-names></name><name><surname>Chu</surname><given-names>CH</given-names></name><name><surname>Tsou</surname><given-names>AP</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Hsu</surname><given-names>PW</given-names></name><etal/></person-group><article-title>miRNAMap 2.0: genomic maps of microRNAs in metazoan
genomes</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><issue>Database issue</issue><fpage>D165</fpage><lpage>D169</lpage><pub-id pub-id-type="pmid">18029362</pub-id></element-citation></ref><ref id="r63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roush</surname><given-names>SF</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name></person-group><article-title>Micromanagement: a role for microRNAs in mRNA
stability</article-title><source>ACS Chem Biol</source><year>2006</year><volume>1</volume><issue>3</issue><fpage>132</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">17163657</pub-id></element-citation></ref><ref id="r64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>CP</given-names></name><name><surname>Bordeleau</surname><given-names>ME</given-names></name><name><surname>Pelletier</surname><given-names>J</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group><article-title>Short RNAs repress translation after initiation in mammalian
cells</article-title><source>Mol Cell</source><year>2006</year><volume>21</volume><issue>4</issue><fpage>533</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">16483934</pub-id></element-citation></ref><ref id="r65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albinsson</surname><given-names>S</given-names></name><name><surname>Suarez</surname><given-names>Y</given-names></name><name><surname>Skoura</surname><given-names>A</given-names></name><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Miano</surname><given-names>JM</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name></person-group><article-title>MicroRNAs are necessary for vascular smooth muscle growth,
differentiation, and function</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2010</year><volume>30</volume><issue>6</issue><fpage>1118</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">20378849</pub-id></element-citation></ref><ref id="r66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boon</surname><given-names>RA</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name></person-group><article-title>MicroRNAs and aneurysm formation</article-title><source>Trends Cardiovasc Med</source><year>2011</year><volume>21</volume><issue>6</issue><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">22814425</pub-id></element-citation></ref><ref id="r67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maegdefessel</surname><given-names>L</given-names></name><name><surname>Azuma</surname><given-names>J</given-names></name><name><surname>Toh</surname><given-names>R</given-names></name><name><surname>Merk</surname><given-names>DR</given-names></name><name><surname>Deng</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Inhibition of microRNA-29b reduces murine abdominal aortic
aneurysm development</article-title><source>J Clin Invest</source><year>2012</year><volume>122</volume><issue>2</issue><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">22269326</pub-id></element-citation></ref><ref id="r68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merk</surname><given-names>DR</given-names></name><name><surname>Chin</surname><given-names>JT</given-names></name><name><surname>Dake</surname><given-names>BA</given-names></name><name><surname>Maegdefessel</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>MO</given-names></name><name><surname>Kimura</surname><given-names>N</given-names></name><etal/></person-group><article-title>miR-29b participates in early aneurysm development in Marfan
syndrome</article-title><source>Circ Res</source><year>2012</year><volume>110</volume><issue>2</issue><fpage>312</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">22116819</pub-id></element-citation></ref><ref id="r69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>S</given-names></name><name><surname>Weng</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>A microRNA profile comparison between thoracic aortic dissection
and normal thoracic aorta indicates the potential role of microRNAs in
contributing to thoracic aortic dissection pathogenesis</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>5</issue><fpage>1341</fpage><lpage>9.e3</lpage><pub-id pub-id-type="pmid">21334170</pub-id></element-citation></ref><ref id="r70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curci</surname><given-names>JA</given-names></name><name><surname>Thompson</surname><given-names>RW</given-names></name></person-group><article-title>Adaptive cellular immunity in aortic aneurysms: cause,
consequence, or context?</article-title><source>J Clin Invest</source><year>2004</year><volume>114</volume><issue>2</issue><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">15254583</pub-id></element-citation></ref><ref id="r71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewster</surname><given-names>DC</given-names></name><name><surname>Cronenwett</surname><given-names>JL</given-names></name><name><surname>Hallett</surname><given-names>JW</given-names><suffix>Jr</suffix></name><name><surname>Johnston</surname><given-names>KW</given-names></name><name><surname>Krupski</surname><given-names>WC</given-names></name><name><surname>Matsumura</surname><given-names>JS</given-names></name><etal/><collab>Joint Council of the American Association for Vascular Surgery and
Society for Vascular Surgery</collab></person-group><article-title>Guidelines for the treatment of abdominal aortic aneurysms.
Report of a subcommittee of the Joint Council of the American Association
for Vascular Surgery and Society for Vascular Surgery</article-title><source>J Vasc Surg</source><year>2003</year><volume>37</volume><issue>5</issue><fpage>1106</fpage><lpage>1117</lpage><pub-id pub-id-type="pmid">12756363</pub-id></element-citation></ref><ref id="r72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGloughlin</surname><given-names>TM</given-names></name><name><surname>Doyle</surname><given-names>BJ</given-names></name></person-group><article-title>New approaches to abdominal aortic aneurysm rupture risk
assessment: engineering insights with clinical gain</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2010</year><volume>30</volume><issue>9</issue><fpage>1687</fpage><lpage>1694</lpage><pub-id pub-id-type="pmid">20508202</pub-id></element-citation></ref><ref id="r73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engstr&#x000f6;m</surname><given-names>G</given-names></name><name><surname>B&#x000f6;rner</surname><given-names>G</given-names></name><name><surname>Lindblad</surname><given-names>B</given-names></name><name><surname>Janzon</surname><given-names>L</given-names></name><name><surname>Lindg&#x000e4;rde</surname><given-names>F</given-names></name></person-group><article-title>Incidence of fatal or repaired abdominal aortic aneurysm in
relation to inflammation-sensitive plasma proteins</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><issue>2</issue><fpage>337</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">14684427</pub-id></element-citation></ref><ref id="r74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackam</surname><given-names>DG</given-names></name><name><surname>Thiruchelvam</surname><given-names>D</given-names></name><name><surname>Redelmeier</surname><given-names>DA</given-names></name></person-group><article-title>Angiotensin-converting enzyme inhibitors and aortic rupture: a
population-based case-control study</article-title><source>Lancet</source><year>2006</year><volume>368</volume><issue>9536</issue><fpage>659</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">16920471</pub-id></element-citation></ref><ref id="r75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxter</surname><given-names>BT</given-names></name><name><surname>Terrin</surname><given-names>MC</given-names></name><name><surname>Dalman</surname><given-names>RL</given-names></name></person-group><article-title>Medical management of small abdominal aortic
aneurysms</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>14</issue><fpage>1883</fpage><lpage>1889</lpage><pub-id pub-id-type="pmid">18391122</pub-id></element-citation></ref><ref id="r76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarins</surname><given-names>CK</given-names></name><name><surname>White</surname><given-names>RA</given-names></name><name><surname>Hodgson</surname><given-names>KJ</given-names></name><name><surname>Schwarten</surname><given-names>D</given-names></name><name><surname>Fogarty</surname><given-names>TJ</given-names></name></person-group><article-title>Endoleak as a predictor of outcome after endovascular aneurysm
repair: AneuRx multicenter clinical trial</article-title><source>J Vasc Surg</source><year>2000</year><volume>32</volume><issue>1</issue><fpage>90</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">10876210</pub-id></element-citation></ref></ref-list></back></article>